Ardsley Advisory Partners LP Vertex Pharmaceuticals Inc Transaction History

Ardsley Advisory Partners LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$187.49 - $221.1 $13.1 Million - $15.5 Million	-70,000 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$207.02 - $241.31 $14.5 Million - $16.9 Million	70,000 New	70,000 $15 Million
Q4 2020 Feb 16, 2021	SELL	$207.01 - $276.09 $621,030 - $828,269	-3,000 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$225.48 - $295.8 $450,960 - $591,600	-2,000 Reduced 40.0%	3,000 $871,000
Q1 2020 May 15, 2020	BUY	$199.77 - $247.81 $399,540 - $495,620	2,000 Added 66.67%	5,000 $1.19 Million
Q4 2019 Feb 14, 2020	SELL	$166.71 - $223.91 $333,420 - $447,820	-2,000 Reduced 40.0%	3,000 $657,000
Q2 2019 Aug 13, 2019	BUY	$164.61 - $190.37 $823,050 - $951,850	5,000 New	5,000 $917,000
Q1 2019 May 15, 2019	SELL	$163.73 - $194.7 $327,460 - $389,400	-2,000 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$151.91 - $192.21 $607,640 - $768,840	-4,000 Reduced 66.67%	2,000 $331,000
Q2 2018 Aug 14, 2018	BUY	$145.72 - $169.96 $145,720 - $169,960	1,000 Added 20.0%	6,000 $1.02 Million
Q1 2018 May 15, 2018	BUY	$151.6 - $177.13 $379,000 - $442,825	2,500 Added 100.0%	5,000 $815,000
Q4 2017 Feb 14, 2018	SELL	$137.28 - $155.55 $2.2 Million - $2.49 Million	-16,000 Reduced 86.49%	2,500 $375,000
Q3 2017 Nov 14, 2017	BUY	$148.13 - $162.24 $2.74 Million - $3 Million	18,500	18,500 $2.81 Million

1,716

225M

1.19M

1.56M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Ardsley Advisory Partners LP, based on Form 13F filings with the SEC.

Stay updated on Ardsley Advisory Partners LP with notifications on news.